Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.21.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 312,910 $ 377,581
Accounts receivable, net 10,114 6,605
Inventory 16,846 13,642
Prepaid expenses and other current assets 4,565 3,089
Contract assets 1,397 1,466
Total current assets 345,832 402,383
Property, plant and equipment, net 129,577 106,795
Patents, net 1,764 1,801
Right-of-use assets 19,329 19,387
Leverage loans receivable 13,408 13,408
Restricted cash 2,320 2,316
Other noncurrent assets 73 111
Total assets 512,303 546,201
Current liabilities    
Accounts payable 10,797 10,610
Accrued liabilities 7,652 9,220
Unearned revenue and contract liabilities 2,336 2,455
Current portion of lease liability 3,058 3,000
Current portion of long-term debt, net 345 25,201
Total current liabilities 24,188 50,486
Private warrants liability 149,635 82,860
Long-term lease liability, net 23,952 24,175
Long-term debt, net 31,316 31,386
Other long-term liabilities 938 1,250
Total liabilities 230,029 190,157
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Common stock, $0.0001 par value; 200,000,000 shares authorized: 85,339,145 and 84,535,640 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively 9 8
Additional paid-in capital 435,782 414,819
Accumulated deficit (153,517) (58,783)
Total stockholders’ equity 282,274 356,044
Total liabilities and stockholders’ equity $ 512,303 $ 546,201